The effects of dietary linoleic acid on reducing serum cholesterol and atherosclerosis development are nullified by a high-cholesterol diet in male and female apoE-deficient mice. 2023

Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
Laboratory of Nutrition Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka819-0395, Japan.

Linoleic acid (LA) has a two-sided effect with regard to serum cholesterol-lowering and pro-inflammation, although whether this fatty acid reduces serum cholesterol and the development of atherosclerosis under high-cholesterol conditions has yet to be ascertained. In this study, we examine the effects of dietary LA on reducing serum cholesterol and atherosclerosis development under high-cholesterol conditions. Male and female apoE-deficient (ApoE-/-) mice were fed AIN-76-based diets containing 10% SFA and 0·04 % cholesterol, 10% LA and 0·04% low cholesterol (LALC), or 10% LA and 0·1% high cholesterol (LAHC) for 9 weeks. The results revealed significant reduction in serum cholesterol levels and aortic lesions with increasing levels of pro-inflammatory biomarkers (urinary isoprostane and aortic MCP-1 mRNA) in male and female LALC groups compared with those in the SFA groups (P < 0·05). Furthermore, whereas there were significant increases in the serum cholesterol levels and aortic lesions (P < 0·05), there was no difference in aortic MCP-1 mRNA levels in male and female LAHC groups compared with those in the LALC groups. A high-dietary intake of cholesterol eliminated the serum cholesterol-lowering activity of LA but had no significant effect on aortic inflammation in either male or female ApoE-/- mice. The inhibitory effect of LA on arteriosclerosis is cancelled by a high-cholesterol diet due to a direct increase in serum cholesterol levels. Accordingly, serum cholesterol levels might represent a more prominent pathogenic factor than aortic inflammation in promoting the development of atherosclerosis.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005260 Female Females
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
June 2009, Bioscience, biotechnology, and biochemistry,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
October 2008, Atherosclerosis,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
January 2013, PloS one,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
November 1979, The American journal of clinical nutrition,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
November 1979, The American journal of clinical nutrition,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
May 2020, Immunobiology,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
August 2016, Journal of lipid research,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
January 2014, PloS one,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
May 2021, Nutrients,
Xingyu Yuan, and Rika Nagamine, and Yasutake Tanaka, and Wei-Ting Tsai, and Zhe Jiang, and Ai Takeyama, and Katsumi Imaizumi, and Masao Sato
September 2016, Nutrition research (New York, N.Y.),
Copied contents to your clipboard!